glp-1 ckd agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity GLP1 Receptor Agonists vs SGLT2-I
Description
My stress scores dropped way down

This mini-review explores the role of gut peptides, particularly glucagonlike peptide-1 (GLP-1), in the improvement in glycemic control resulting from VSG and RYGB procedures

[DOI] [PMC free article] [PubMed] [Google Scholar] [28].Lim R, Beekley A, Johnson DC, Davis KA
Set up reminders and tracking systems Schedule weekly reminders for your injection day

Toujeo does not interact with GLP-1 receptors

In early 2022, I recall seeing another shift in utilization from GLP-1s with less weight loss benefit (Victoza, Soliqua, Trulicity, etc.) to Ozempic and Mounjaro, creating a consolidation in usage that along with other factors likely led to minor rebate improvement but increased initial costs
